Employer with a benefit plan ยท SEC filer
SIO GENE THERAPIES
Also filed as Axovant Gene Therapies Ltd.; Axovant Sciences Ltd.; Roivant Neurosciences Ltd.
130 WEST 42ND STREET, NEW YORK, NY 10036
EIN
85-3863315
Benefit plan 1, 2024 filing
SIO GENE THERAPIES 401(K) PLAN
DOL · 2025-04-29
Participants (start of year)
1
DOL · 2025-04-29
Plan assets (end of year)
$0
DOL · 2025-04-29
Plan features
code 2F2G2J2K2T3D
DOL · 2025-04-29
Plan type
Multiemployer plan
DOL · 2025-04-29
Business code (NAICS)
325410
DOL · 2025-04-29
Benefit plan 1, 2024 filing
SIO GENE THERAPIES 401(K) PLAN
DOL · 2025-04-29
Participants (start of year)
74
DOL · 2025-04-29
Plan assets (end of year)
$29,262
DOL · 2025-04-29
Plan features
code 2F2G2J2K2T3D
DOL · 2025-04-29
Plan type
Multiemployer plan
DOL · 2025-04-29
Business code (NAICS)
325410
DOL · 2025-04-29
Benefit plan 1, 2023 filing
SIO GENE THERAPIES 401(K) PLAN
DOL · 2024-06-20
Participants (start of year)
81
DOL · 2024-06-20